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Olecranon Bursitis Secondary to Mycobacterium kansasii
Infection in a Patient Receiving Infliximab for Behçet's
Disease
Joanne Malkin, Anna Shrimpton, Martin Wiselka,
Michael Duddridge, Mike Barer, Nelun Perera. University Hospitals
of Leicester Microbiology, Level 5 Sandirngham Building,
Leicester Royal Infirmary Infirmary, Leicester, United Kingdom
Introduction: A 53 year old female with Behçet' s disease on regular
infusions of infliximab, methotrexate and oral steroids presented
in November 2005 with a tender, fluctuant swelling over the back
of her right elbow. Examination confirmed a right olecranon bursi-
tis and she was commenced on a 6 week course of flucloxacillin.
Her symptoms improved except for a residual swelling. She pre-
sented again in July 2006 with increasing swelling and discomfort
of the right elbow together with similar symptoms in the left el-
bow. A diagnosis of bilateral olecranon bursitis was made. Fluid
was aspirated from both bursae and sent to the microbiology lab-
oratory for bacterial, fungal and mycobacterial cultures. Growth
of a mycobacterium species was detected on liquid and solid cul-
ture media from the fluid of the right bursa and was confirmed
as Mycobacterium kansasii using the HAIN GenoType DNA strip.
She was treated initially with clarithromycin, ethambutol and ri-
fampicin and was changed to ethambutol and rifampicin after 2
months. Despite significant improvement of the pain and discom-
fort she underwent bilateral resection of both bursae due to the
persistence of swelling of both bursae. Currently she is the 16th
month of an 18-month course of antituberculous medication and is
doing well.
Discussion: M. kansasii is a non-tuberculous mycobacterium that
commonly causes pulmonary infections in both healthy and im-
munocompromised hosts following inhalation of infected droplets
into the lungs and is clinically indistinguishable from tuberculo-
sis. Disseminated infections have been reported commonly in im-
munocompromised hosts. There is only one published case report
of olecranon bursitis with M. kansasii; this case followed a lacera-
tion acquired in a swimming pool. In this case there was no history
suggestive of direct inoculation of the organism into the bursa;
however there was immunosuppression due to therapy for the Be-
hçet' s disease. This raises the possibility of disseminated infection
although the primary focus of infection could not be established.
Conclusion: This case highlights a rare manifestation of an oppor-
tunistic infection in an immunocompromised patient as well as the
possibility of a disseminated infection. The need for early aspira-
tion and appropriate microbiological investigations cannot be over-
emphasised. A treatment regime including rifampicin for at least 9
months with or without surgery is recommended.
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Correlation of Clinical Symptoms and Positive Urine
Culture (UC) in Patients with Diabetes Mellitus Type 2
Evangelia Ikonomopoulou1, Irini Katsarou2, Ioanna Stauropoulou1,
Panagiota Masoura1, Aggeliki Regli1. 1Microbiological Unit of
General Hospital “St.Andrew' s” Patras, Greece; 2Renal Unit of
General Hospital of Zakynthos, Greece
Introduction: Diabetes mellitus is a factor for the growth of urinary
infections. Our objective was to confirm the correlation between
positive urine culture and clinical symptoms of patients with dia-
betes mellitus Type 2.
Materials and Methods: We studied 300 of patients with UC (105
men and 195 women) suffering from diabetes mellitus Type 2 un-
der treatment in the pathological clinic. We recorded the clinical
symptoms concerning the positive UC. The identification and the
control of sensitivity of UC was performed using either the VITEK
system or using the mini API system (BioMerieux). Positive UC were
considered with the growth of 102 CFU/ml of microbe.
Results: 84 (28%) patients (48 women and 36 men) had UC. The
following microbial organisms were isolated: 42 (50%) Escherichia
coli, 10 (11.9%) Klebsiella spp. and Coag(–) staphylococci, 7 (8.3%)
Enterococcus faecalis and Pseudomonas aeruginosa, 6 (7.1%) Pro-
teus spp., and 2 (2.4%) Streptococcus group B. In general urine
tests the 68 samples had < 5 leucocytes at optical field. Clinically
coincidental were 30 (62.50%) women and 11 (30.55%) men.
Conclusions: Urinary tract infection was frequent (28%) in the pa-
tients with diabetes mellitus. In 48.8% there were no explicit clini-
cal symptoms due to the diabetic neuropathy. Because the polyuria
and rarefaction of urine it is not accompanied with important
leukocyturia (81%). These elements render essential a urine cul-
ture even when the clinical symptoms and urine findings are not
indicative of an infection. As in the general population the women
were more prone to urinary infection than men and the most com-
mon microbial agent was E. coli.
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Laboratorial Picture of Human Brucellosis
Evdokia Ikonomopoulou1, Maria Gioka1, Irini Katsarou2,
Paraskevi Michail1, Sotiris Paratiras1, Chrisoula Verra1,
Gianna Stavropoulou1, Panajota Masoura1, Aggeliki Regly1.
1Microbiological Unit of General Hospital S`t. Andrew' , Patras,
Greece; 2Renal Unit of General Hospital of Zakynthos, Greece
Introduction: Brucellosis is a zoonotic infection transmitted from
animals to humans by ingestion of infected food products, direct
contact with an infected animal, or inhalation of aerosols. Our ob-
jective was to record the laboratorial discoveries of the infection
and the relation with sex and the age of patients.
Methods and Materials: We retrospectively studied 225 cases of
brucellosis that were under treatment between 1995 until 2005 in
the Pathological clinic. We recorded the age, the sex and their
relation with laboratorial control at the input in the hospital.
Results: The age of the patients varied from 16 to 88 years old.
154 (68.40%) patients were men. The professional activity had cor-
relation with the infection in 56 (24.88%) from the patients, all
men.
Laboratorial control Patients (%)
Neutropenia 45 20.00
Leucopenia 21 9.33
Anemia 14 6.22
Thrombocytopenia 5 2.22
Increase of ESR 50 22.22
Increase of CRP 135 6.00
Increase of liver enzymes 23 10.22
Increase of the urea 14 6.22
Electrolyte' s disturbances 10 4.44
Wright' s serum agglutination titer of 1/160 or greater had the ma-
jority of 209 patients (92.88%). The total who were culture positive
was 89 patients (39.56%) from which 73 (32.44%) were from blood
and 16 (7.11%) from bone marrow.
Conclusions: The laboratorial control was not characteristic for
brucellosis. The neutropenia in our study was near 20%, while bib-
liographically it is reported as normal. As for the age-relation, the
sickness concerns all ages due to the different kinds of pollution.
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The profession was connected closely with the men' s population.
Because of the frequency of illness (1-36/100.000) in the Mediter-
ranean region the brucellosis should always be considered in the
differential diagnosis of prolonged fever.
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Intravascular Device-related Infections in Neurosurgical
Patients: Incidence and Predictors
Nikolaos Syrmos, Vasilios Valadakis, Konstantinos Grigoriou,
Stefanos Patiakas, Dimitrios Arvanitakis. Neurosurgical
Department, Venizeleio General Hospital, Heraklion, Crete,
Greece
Introduction: The rate intravascular device-related infection
varies widely depending most of the times in factors such as- the
nature of the procedure, the patient' s diagnosis, the patient sta-
tus, the nursing comorbidities and other risk factors.
Objective: The objective of our study was to find the frequency
of the colonization of intravascular catheters in neurosurgical pa-
tients.
Materials and Methods: During a five-year period (2002-2007) cul-
tures of the cotton swabs and tips of 150 catheters were done by
qualitative and semiquantitative methods.
Results: The mean colonization rate of the catheter tips was 15,
5%. The most frequent isolates were Gram-positive Staphylococcus
aureus, Staphylococcus epidermidis, CNS etc and Gram-negative
Pseudomonas aeruginosa, Acinetobacter baumanni, etc.
Conclusions: Intravascular catheters are frequently colonized.
These types of infections are a major problem in neurosurgical pa-
tients' . The collaboration between neurosurgeons and laboratory
medical staff is necessary for the best final result.
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The Susceptibility Analysis of Fungal Strains to
Posaconasole in vitro Isolated from Cinical Specimens of
Patients Hospitalized in Warsaw Medical University Central
Clinical Hospital
Ewa Swoboda-Kopec, Sylwia Blachnio, Dariusz Kawecki,
Beata Sulik-Tyszka, Ewa Stelmach, Miroslaw Luczak. Department
of Medical Microbiology, Medical University of Warsaw, Warsaw,
Poland
Introduction: The increasing resistance of fungal strains to anti-
fungal agents is the main reason of research on the new antifun-
gals.
Objectives: The susceptibility analysis of fungal strain isolated
from patients hospitalized in Warsaw Medical University Central
Clinical Hospital in 2007 to Posaconazole in vitro.
Materials and Methods: The clinical material was consisted of:
blood samples 33 (43.4%), respiratory tracts specimens (23.7%),
wound swabs 16 (21%), urine samples 4 (5.3%) and other 5 (6.6%).
Strains were cultured on Sabouraud and CHROMagar media and
identify by ID32C tests. The susceptibility analysis to Posaconazole
was done according to E-tests.
Results: From the total number of 76 positive samples we cultured
87 of fungal strains. The following species were cultured C. gal-
brata 41 (47%), C. albicans 12 (14%), C. krusi 10 (11.5%), C. para-
psilosis 6 (7%), C. inconspicua 4 (4.5%), Saccharomyces cerevisiae
4 (4.5%), other 10 (11.5%). We isolated 83 strains of the yeast like
fungi (95% out of all isolates) and two species of molds (5% of all
isolates): Aspergillus fumigatus 2 strains and Fusarium incarnatum
2. Our results were analyzed according to ARTEMIS Program. The fi-
nal Posaconazole concentration was 0,008 to 32ug/ml. In our study
the break point was 1 ug/ml and it was established as the agent
activity. Posaconazole was active for 83 isolates (95% casus) and it
had the break point 1 ug/ml. The all resistant isolates were from
the same species of C. glabrata. Posaconazole had not been active
for 4 (5%) of isolates.
Conclusions: 10% of C. glabrata isolates were Posaconazole resis-
tant. Posaconazole was active for 95% of isolated strains.
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Fungiscope – a Global Registry for Rare Fungal Infections
Maria Rüping1, Jörg Vehreschild1, Claudia Beisel1,
Carsten Müller1, Guido Fischer2, Claudia Wickenhauser1,
Oliver Cornely1. 1Uniklinik Köln, Klinik I für Innere Medizin,
Germany; 2RWTH Aachen, Germany
Background: The incidence of invasive fungal infections increases
worldwide, and rare fungi - neither belonging to the genera As-
pergillus, Candida, Pneumocystis or Cryptococcus, nor being en-
demic, is increasingly identified as causative pathogens.
Methods: We are coordinating a global registry for cases of rare
invasive fungi. Our objective is to broaden the knowledge on epi-
demiology, to determine the clinical pattern of disease, to describe
and improve diagnostic procedures and therapeutic regimens, as
well as to facilitate exchange of clinical isolates among the con-
tributors. Entry of retrospective data occurs via a web-based regis-
tration system (MACRO) that focuses on demographic information,
underlying diseases, risk factors, details on the infection, therapy
and outcome. Inclusion criteria include cultural, histopathological,
antigen, or DNA evidence of invasive fungal infection. Infection
due to Aspergillus spp., Candida spp., Cryptococcus neoformans,
Pneumocystis jiroveci or any endemic fungal infection, as well as
mere colonization or other non-invasive infections are exclusion
criteria. For evaluable patient documentations, authorship posi-
tions in resulting publications will be available and a compensation
of €100 each will be paid. If the documentation workload is too
high, centers are encouraged to ask the study office for personnel
to be sent to the site. For isolates made available to the central
laboratory an additional €50 will be paid. Plasma levels of all com-
mon antifungals can be determined from serum, liquor, and other
tissue samples. This service is provided for free to all participating
investigators.
Results: By now, 20 cases of rare invasive fungal infections
have been identified, including Mucoclades corymbifera, Cunning-
hamella bertholletiae, Penicillium marneffei, Rhizomucor pusil-
lus, as well as Acremonium spp., Fusarium spp., Coccidioides spp.,
and Trichoderma spp. Clinical results are partly pending. Most pa-
tients were in an immunocompromised state as a result of their
underlying disease, chemotherapy or transplantation.
Discussion: The clinical relevance of invasive fungal infections by
rare fungi is increasing steadily. In a short period of time, actual
cases from Germany, Austria, Italy and the United Kingdom could
be documented, showing the broad spectrum of pathogens. Further
investigators and coordinators are cordially invited to contribute to
the success of Fungiscope.
109
A 61-year Old Immunocompromised Man with Disseminated
Cryptococcosis
Maria Katsiari1, Maria Laskou1, Zoe Roussou2,
Anna Mihalopoulou3, Sotiris Haramoglis4, Nina Maguina1. 1ICU,
2Microbiology Department, 3Pathology Department,
Konstantopoulion Hospital, Athens; 4Urology Department,
Metropolitan Hospital, Athens, Greece
Background: Cryptococcosis is rare and occurs mainly in immuno-
